Skip to main content

Table 1 Patient demographics of ITT population

From: Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study

 

Rosuvastatin (n = 232)

Atorvastatin (n = 233)

Gender, male/female (%)

128/104 (55.2/44.8)

136/97 (58.4/41.6)

Race, white (%)

229 (98.7)

229 (98.3)

Mean age, years (SD)

63.5 (8.8)

65.0 (8.6)

Mean weight, kg (SD)

84.8 (14.3)

82.5 (13.5)

Mean BMI, kg/m2 (SD)

29.0 (3.6)

28.4 (3.6)

Mean baseline LDL-C, mmol/L (SD)

4.6 (0.85)

4.6 (0.82)a

Mean baseline HDL-C, mmol/L (SD)

1.2 (0.27)

1.2 (0.27)a

Mean baseline TG, mmol/L (SD)

2.0 (1.0)

2.0 (0.93)a

  1. ITT: Intention to treat, SD: Standard deviation, BMI: Body mass index, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol, TG: Triglycerides
  2. an = 232
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840